These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 5603692

  • 1. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid].
    Tesi M, Brunetti S, Caramelli L.
    Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692
    [No Abstract] [Full Text] [Related]

  • 2. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].
    Tesi M.
    Riv Crit Clin Med; 1967 Dec; 67(6):465-83. PubMed ID: 5603691
    [No Abstract] [Full Text] [Related]

  • 3. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR.
    Acta Chir Scand Suppl; 1971 Dec; 421():1-51. PubMed ID: 5292287
    [No Abstract] [Full Text] [Related]

  • 4. [Changes in the coagulation and anti-coagulation systems of the blood under the influence of nicotinic acid].
    Kiseleva LN, Romanenko GK.
    Klin Med (Mosk); 1966 Jan; 44(1):48-50. PubMed ID: 5988141
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Nicotinic acid level in the blood and fibrinolysis under the influence of hexanicotinic acid esters of m-inositol].
    Sommer H.
    Arzneimittelforschung; 1965 Nov; 15(11):1337-9. PubMed ID: 5340070
    [No Abstract] [Full Text] [Related]

  • 8. Fibrinogen turnover during the treatment with xantinol nicotinate.
    Cultrera G, Giarola P, Gibelli A, Baldoni E, Cuttin S, Galetti G, Serenth'a P.
    Arzneimittelforschung; 1971 Jul; 21(7):954-7. PubMed ID: 5109508
    [No Abstract] [Full Text] [Related]

  • 9. [Action mechanism of nicotinic acid on fibrinolysis in vitro and in vivo].
    Andreenko GV, Migalina LA.
    Vopr Med Khim; 1971 Jul; 17(4):423-7. PubMed ID: 5317629
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].
    Buzzelli G, Doni A, Lippi G, Resina A.
    Clin Ter; 1979 May 15; 89(3):251-66. PubMed ID: 466976
    [No Abstract] [Full Text] [Related]

  • 12. [Studies on the effect of nicotinic acid and adenosine monophosphate on skin and muscle circulation in healthy subjects and patients with peripheral circulatory disorders].
    Gottstein U, Felix R, Flad HD, Sedlmeyer I.
    Z Kreislaufforsch; 1966 Oct 15; 55(10):970-87. PubMed ID: 5994974
    [No Abstract] [Full Text] [Related]

  • 13. [Our experience using nicotinic acid for preventing thromboembolic complications].
    Chekalina SI, Tokarev OIu.
    Sov Med; 1982 Oct 15; (5):105-8. PubMed ID: 7112226
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Fibrinolytic action of Complamin (R). Preliminary report].
    Harel P, Gauthier J.
    Union Med Can; 1966 May 15; 95(5):542-5. PubMed ID: 5932651
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical and experimental research on prolonged fibrinolytic treatment. 2. Activation of fibrinolysis by prolonged administration of nicotinic acid derivatives].
    De Nicola P, Gibelli A, Frandoli G, Turazza G.
    Hemostase; 1965 Dec 15; 5(4):343-51. PubMed ID: 5880346
    [No Abstract] [Full Text] [Related]

  • 17. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G, Spreafico PL, Frandoli G.
    Arzneimittelforschung; 1973 May 15; 23(5):654-7. PubMed ID: 4575777
    [No Abstract] [Full Text] [Related]

  • 18. Fibrinogen turnover in the aged subjects following the administration of drugs acting on fibrinolysis.
    De Nicola P, Cultrera G, Manai G.
    Farmaco Sci; 1968 Oct 15; 23(10):994-8. PubMed ID: 5712798
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Cardiovascular changes caused by nicotinic acid (author's transl)].
    Rauer MP, Wüst HJ, Antons H, Sandmann W.
    Anasth Intensivther Notfallmed; 1980 Apr 15; 15(2):107-18. PubMed ID: 7396099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.